Clinical trial
Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced…
NCT00152828 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00152828 |
|---|---|
| Title | Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix |
| Official title | A Phase I/II Trial of the Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | NCIC Clinical Trials Group Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cervix Neoplasms |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Enrollment | 31 |
| Start date | Feb 1, 2001 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Sep 9, 2005 |
| Last update posted | Feb 9, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: